Antiviral Intervention of COVID-19: Linkage of Disease Severity with Genetic Markers FGB (rs1800790), NOS3 (rs2070744) and TMPRSS2 (rs12329760)
М.О. Соколенко(Bukovinian State Medical University), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Valentyn Oksenych(University of Bergen), Andriy Sydorchuk(St. Anna Hospital), Oleksandr Sokolenko(Bukovinian State Medical University), Iryna Kamyshna(I.Horbachevsky Ternopil National Medical University), Ludmila Sokolenko(Pavlo Tychyna Uman State Pedagogical University), Аліна Соколенко(Bukovinian State Medical University), Larysa Sydorchuk(Bukovinian State Medical University), Ruslan Sydorchuk(Bukovinian State Medical University)
Cited by 1
Related Papers
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
|Biomedicines|2024|51
Current treatment options for leptospirosis: a mini-review
|Frontiers in Microbiology|2024|48